Roche Signs Exclusive Distribution Deal with DxS for K-RAS and EGFR Cancer Mutation Tests
Tests identify genetic mutations that can affect patient response to certain cancer drugs PLEASANTON, Calif., June 2 /PRNewswire/ -- Roche and DxS Ltd. have signed an exclusive distribution agreement for the DxS TheraScreen K-RAS Mutation Test and TheraScreen EGFR 29...Tissue Specificity for Mutation Parallels Tissue Specificity for Cancer
Measure mutations in any tissue with the Big Blue transgenic rodent mutation assay Johan G. de Boer Barry W. Glickman Centre for Environmental Health, University of Victoria, Victoria, BC Canada With Stratagenes Big Blue transgenic rodent mutation assay,* which carrie...Organize Your Data from the Big Blue Mutation Assay
Record, analyze, and report data with the MutaTrak electronic notebook G. (Paul) Kotturi Mark J. Dycaico Stratagene Marc Hamovitch Doug Schroeder Solana Consulting Group, Solana Beach, CA Stratagene introduces the MutaTrak electronic notebook to record Big Blue...A Positive Selection Assay for Mutation Analysis in Big Blue Animals
Cost-effective and easy-to-use l Select-cII mutation assay kit A Positive Selection Assay for Mutation Analysis in Big Blue Animals Mark J. Dycaico Gabriela M. Tobal Stratagene Stratagene now offers an alternative way to perform mutational analysis in ...SEQUENOM Announces Launch of MassARRAY Compact 96 System
...p; marketing at SEQUENOM. "MassARRAY technology enables detection of the most common molecular biomarker classes - somatic mutations via the OncoCarta mutation panel, SNPs, CNVs, methylation patterns, expression signatures - with an unmatched combination of quantitative accuracy and sensitivity. This is the t...CEL-SCI Corporation Releases Letter to Shareholders
...xico. At this meeting the WHO's Director General was underscoring the unstoppable nature of swine flu and its potential to mutate - "Constant, random mutation is the survival mechanism of the microbial world. Like all influenza viruses, H1N1 has the advantage of surprise on its side." At the same time, the ...PTC Therapeutics Receives $2.6 Million in Government Grants
...pivotal trial of ataluren (PTC124(TM)) in nonsense mutation Duchenne and Becker muscular dystrophy (nmDMD/BMD)...ed as a new approach for the treatment of nonsense mutation genetic disorders. Nonsense mutations create a pr... is a potential therapy for patients with nonsense mutation genetic disorders. Ataluren has demonstrated ...MEDomics Announces MitoDx(TM), the First NextGen Mitochondrial Genome Diagnostic Test
...s not suspect the disease or because the causative mutation is missed by current methods. " To my knowle... S. Sommer, MD, PhD, with the mission of providing mutation Expert-based Diagnosis ("MED") to support the phys...n analysis of the patient's genome ("omics"). The mutation experts at MEDomics provide unparalleled quality i...Transgenomic, Inc. Announces Appointment of New Board Members
...ces lab, plus focusing our WAVE system and related mutation detection technology for greater diagnostic and cl...r automated high sensitivity genetic variation and mutation analysis. Their offerings include systems, product...heir technology and expertise to provide a menu of mutation scanning tests for over 700 cancer-associated gene...Transgenomic, Inc. Reports First Quarter 2009 Results
... products and services for automated high sensitivity genetic variation and mutation analysis. Their offerings include systems, products, discovery and laborato...ces divisions utilize these technologies and expertise to provide a menu of mutation scanning tests for over 700 cancer-associated genes and more than 60 valida...Reminder: Transgenomic Inc. Announces First Quarter 2009 Earnings Release Conference Call Webcast
... products and services for automated high sensitivity genetic variation and mutation analysis. Their offerings include systems, products, discovery and laborato...ces divisions utilize these technologies and expertise to provide a menu of mutation scanning tests for over 700 cancer-associated genes and more than 60 valida...Chromosome breakpoints contribute to genetic variation
...than other parts of the chromosome. In 2005, Lewin's team showed that breakpoint regions also have higher numbers of segmental duplications, a type of mutation that increases the copy number of genes and the sequences that flank them. "To me, this was completely counterintuitive. I thought we would have th...Patent for Making Combination Chemotherapy Work Better
... Mark Zamoyski of San Jose, California discloses an improved method of treating lung, brain, pancreatic, breast and colon cancers that are driven by a mutation known as HER1 overexpression (also called EGFR or c-ErbB-1). The patent presents a case for why today's concurrent HER1 blocker / S-Phase cytotoxic p...Cytopia Scientific Presentation on JAK2 Inhibitor Program at American Chemical Society Conference
...lar disrupting agent (VDA), CYT997, has also been presented at the same conference. About JAK2 The discovery of a specific single activating mutation in the JAK2 enzyme in MPDs in 2005 has focused attention on developing a therapy for these diseases through selective inhibition of JAK2. T...Transgenomic, Inc. Reports Fourth Quarter and Fiscal Year 2008 Results
...ing a full product line of key cancer pathway gene mutation kits to complement our WAVE and Surveyor products ... product combo will be enhanced with specific gene mutation kits based on our experience in clinical trial ass...r automated high sensitivity genetic variation and mutation analysis. Their offerings include systems, product...Discovery of a new retinal gene involved in childhood blindness
...total of fifteen genes involved in LCA, but SPATA7 is the first gene with a mutation that disrupts the protein transport between two important compartments of t...pass through this transport pathway; thus SPATA7 plays a major role and its mutation may affect many aspects of vision. "Until now we were not aware that th...Transgenomic Awarded Clinical Laboratory Certification in California
... products and services for automated high sensitivity genetic variation and mutation analysis. Their offerings include systems, products, discovery and laborato...ratory Services utilize their technology and expertise to provide a menu of mutation scanning tests for over 700 cancer-associated genes and more than 60 valida...VAP Cholesterol Test Helps In Search For New Heart Disease Drugs
...hers have found an association between a rare gene mutation and heart protection. The information reported in ...ted journal, Science, identified a specific gene mutation ( APOC3 R19X) present in 5 percent of a Lancaster...igator, said participants who were carriers of the mutation had one of their inherited APOC3 genes "switched...Lentigen and Expression Therapeutics Sign Hemophilia Co-Development Agreement
...ative agreement to co-develop novel cell and protein therapies for Hemophilia A. Hemophilia A is an inherited blood clotting disorder caused by a mutation in the factor VIII gene resulting in a deficiency of factor VIII protein. Lentigen and Expression Therapeutics will develop two types of treatments fo...Sangamo BioSciences Initiates Phase 1 Trial of CCR5-ZFP Therapeutic to Treat HIV/AIDS
...t was observed that individuals carrying a natural mutation of their CCR5 gene, CCR5-delta32, were highly resi...and matched donors who also carry the CCR5-delta32 mutation are likely to be rare. Small molecule or antibody ...ins. A small fraction of the population carries a mutation in their CCR5 gene, called the delta32 mutation. ...Chronic Lung Disease - Axentis Pharma Attracts Investment Interest
...ereditary disease amongst Caucasian populations. The disease is caused by a mutation in the CFTR (cystic fibrosis transmembrane conductance regulator) gene found on chromosome 7. This mutation causes increased secretion deposits on mucous membranes. Lung complications...First Patient Dosed in Phase 2 Clinical Trial of NKTR-102 in Ovarian Cancer
...ment in progression-free survival as compared to standard irinotecan monotherapy. It is estimated that up to 45% of colorectal cancer cases have this mutation in the KRAS gene and do not respond to EGFR-inhibitors, such as cetuximab. The NKTR-102 Phase 2 studies in ovarian, breast, and cervical cancer...Transgenomic Receives Accreditation From College of American Pathologists
... instruments and consumables with our related expertise in high sensitivity mutation detection analysis. We plan to immediately pursue the benefits of the accre...ratory Services utilize their technology and expertise to provide a menu of mutation scanning tests for over 700 cancer-associated genes and more than 60 valida...